OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 47 citing articles:

Structural and molecular characterization of lopinavir and ivermectin as breast cancer resistance protein (BCRP/ABCG2) inhibitors.
Júlia de Paula Dutra, Gustavo Scheiffer, Thales Kronenberger, et al.
PubMed (2023) Vol. 22, pp. 1155-1172
Closed Access | Times Cited: 3

Population pharmacokinetic model of ivermectin in mass drug administration against lymphatic filariasis
Abdullah Alshehri, Yashpal S. Chhonker, Veenu Bala, et al.
PLoS neglected tropical diseases (2023) Vol. 17, Iss. 6, pp. e0011319-e0011319
Open Access | Times Cited: 2

Pharmacological therapy with azithromycin, hydroxychloroquine and ivermectin increased gastrointestinal side effects in a population in northeast Brazil
Gabriella Pacheco, Andreza Ketly da Silva Araújo, André Luís Fernandes Lopes, et al.
Peer Review (2024) Vol. 6, Iss. 3, pp. 156-169
Open Access

Targeting ACSS2 activity suspends the formation of chemoresistance through suppressed histone H3 acetylation in human breast cancer
Xiaoxi Shui, Liying Tian, Yuepeng Zhou, et al.
Research Square (Research Square) (2024)
Closed Access

Biotransformation of hydroxychloroquine to evaluate the cytotoxicity of its metabolites and mimic mammalian metabolism
Valmore Henrique Pereira dos Santos, Wanderleya Toledo dos Santos, Marisa Ionta, et al.
Results in Chemistry (2023) Vol. 5, pp. 100761-100761
Open Access | Times Cited: 1

Ivermectin as an Anti‐Inflammatory Agent
Mudasir Nabi Peerzada, Saurabh Verma
(2023), pp. 141-161
Closed Access | Times Cited: 1

Transcriptomic Investigation of NP Toxicity on HepaRG Spheroids
Merve Erden Tüçer, Nazlıcan Tunç, Suat Tüçer, et al.
Chemico-Biological Interactions (2024) Vol. 405, pp. 111303-111303
Closed Access

Pharmacometric Analysis to Describe Pharmacokinetics and Exposure‐Efficacy Response of Ivermectin in Adolescents Infected with Trichuris trichiura
David Taiwo Ajayi, Ochuko M. Orherhe, Goonaseelan Pillai, et al.
The Journal of Clinical Pharmacology (2024)
Closed Access

HIGH DOSES OF IVERMECTIN CAUSE TOXIC EFFECTS AFTER SHORTTERM ORAL ADMINISTRATION IN RATS
Vladimir Marjanović, Dragana Medić, Djordje S. Marjanović, et al.
Slovenian Veterinary Research (2024)
Open Access

Traitement des parasitoses intestinales (amœbose exclue)
C. Prieux-Klotz, M.-C. Sabate Ferris, Ling Gan, et al.
EMC - Gastro-entérologie (2024) Vol. 41, Iss. 2, pp. 1-15
Closed Access

Ivermectin induces chicken BCRP/ABCG2 expression and function: Involvement of CXR signaling pathway and mRNA stabilization
Ziyong Xu, Mei Li, Lu Wang, et al.
Journal of Veterinary Pharmacology and Therapeutics (2022) Vol. 45, Iss. 6, pp. 558-569
Closed Access | Times Cited: 2

Perceptions of self-medication of the population, during the covid-19 pandemic in Peru
Luis Alberto Inostroza-Ruiz, Paul Iván Gutiérrez Elescano, Nelson Bautista Cruz, et al.
Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo (2021) Vol. 14, Iss. 4, pp. 479-483
Open Access | Times Cited: 2

Natural Products as an Alternative Therapy for Brain Tumors
Sachin Kumar, Mandeep Kumar, Anjali Bijalwan, et al.
Handbook of Oxidative Stress in Cancer: Therapeutic Aspects (2022), pp. 653-677
Closed Access | Times Cited: 1

Altered Gene Expression of Cytochrome P450 and ABC Transporter in Human Hepatocellular Carcinoma HepG2 Cells Exposed to Bardoxolone Methyl
Katsuhito Nagai, Shuhei Fukuno, Takeshi Miura, et al.
Drug Research (2023) Vol. 73, Iss. 08, pp. 473-475
Closed Access

Toxicology, Safety, and Environmental Aspects of Ivermectin
Ayesha Akhtar, Nasreen Mazumdar, Afreen Inam
(2023), pp. 247-264
Closed Access

Development of Fast, Precise and Selective RP-HPLC Methods for Identification of Possible Degradation Products of Ivermectin in Isolated Rat Hepatocytes and in Different pH Media
Alexandrina Dineva, Borislav Angelov, Magdalena Kondeva-Burdina, et al.
Indian Journal of Pharmaceutical Education and Research (2022) Vol. 56, Iss. 2, pp. 546-552
Open Access

Natural Products as an Alternative Therapy for Brain Tumors
Sachin Kumar, Mandeep Kumar, Anjali Bijalwan, et al.
Handbook of Oxidative Stress in Cancer: Therapeutic Aspects (2022), pp. 1-26
Closed Access

A possível citotoxicidade desenvolvida pelo uso de ivermectina em pacientes com COVID-19: uma revisão integrativa
Danieli Henriques da Silva, Darling Lorena Barros Orozco, Eduardo Coroa, et al.
Research Society and Development (2022) Vol. 11, Iss. 11, pp. e555111133611-e555111133611
Open Access

Indicaciones de la ivermectina oral en dermatología
D. Morgado‐Carrasco, Jaime Piquero‐Casals, Sebastián Podlipnik
Piel (2021) Vol. 37, Iss. 2, pp. 113-117
Closed Access

Previous Page - Page 2

Scroll to top